Clinical Study

Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer

Table 4

Univariate and multivariate Cox regression analysis for the prognostic factors of overall survival.

UnivariateMultivariate
valueHR (95% CI) valueHR (95% CI)

Age (years) ≥650.269
Male0.761
Oropharynx 0.0140.391 (0.185–0.829)0.0000.261 (0.116–0.586)
Extracapsular spread0.0122.443 (1.219–4.895)0.0072.709 (1.312–5.592)
Pathologic staging
 pT > 20.894
 pN > 10.472
p16INK4A0.583
Regional lymph node involvement0.501
Resection margin status0.891
Tumor emboli0.476
Perineural invasion0.611
Lymphovascular invasion0.892
Total radiation dose ≥60 Gy0.0120.285 (0.107–0.761)0.0070.241 (0.086–0.679)
Weekly chemotherapy ≥7 cycle0.152

HR: hazard ratio; CI: confidence interval.